240 related articles for article (PubMed ID: 34268631)
41. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
Martinka E; Rončáková M; Mišániková M; Davani A
Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
[TBL] [Abstract][Full Text] [Related]
42. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
[TBL] [Abstract][Full Text] [Related]
43. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
Kawasaki E; Awata T; Ikegami H; Imagawa A; Oikawa Y; Osawa H; Katsuki T; Kanatsuna N; Kawamura R; Kozawa J; Kodani N; Kobayashi T; Shimada A; Shimoda M; Takahashi K; Chujo D; Tsujimoto T; Tsuchiya K; Terakawa A; Terasaki J; Nagasawa K; Noso S; Fukui T; Horie I; Yasuda K; Yasuda H; Yanai H; Hanafusa T; Kajio H;
J Diabetes Investig; 2024 Jul; 15(7):835-842. PubMed ID: 38451108
[TBL] [Abstract][Full Text] [Related]
44. The prevalence and characteristics of latent autoimmune diabetes in adults subset among type two diabetes mellitus patients in Northern Nigeria.
Muazu SB; Okpe I; Anumah F
Ann Afr Med; 2016; 15(4):163-170. PubMed ID: 27853030
[TBL] [Abstract][Full Text] [Related]
45. Clinical heterogeneity of adult Japanese diabetes depending on titers of glutamic acid decarboxylase autoantibodies.
Aoyama T; Ikeda H; Hamamoto Y; Honjo S; Nomura K; Wada Y; Fujikawa J; Hayashino Y; Fukuhara S; Koshiyama H
J Diabetes Investig; 2012 Jun; 3(3):266-70. PubMed ID: 24843575
[TBL] [Abstract][Full Text] [Related]
46. Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes.
Wilmot-Roussel H; Lévy DJ; Carette C; Caillat-Zucman S; Boitard C; Timsit J; Dubois-Laforgue D
Diabetes Metab; 2013 May; 39(3):244-9. PubMed ID: 23522731
[TBL] [Abstract][Full Text] [Related]
47. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
[TBL] [Abstract][Full Text] [Related]
48. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
[TBL] [Abstract][Full Text] [Related]
49. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
Rattarasarn C; Diosdado MA
Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of latent autoimmune diabetes of adults (LADA) in Southern Spain.
Soriguer-Escofet F; Esteva I; Rojo-Martinez G; Ruiz de Adana S; Catalá M; Merelo MJ; Aguilar M; Tinahones F; García-Almeida JM; Gómez-Zumaquero JM; Cuesta-Muñoz AL; Ortego J; Freire JM;
Diabetes Res Clin Pract; 2002 Jun; 56(3):213-20. PubMed ID: 11947969
[TBL] [Abstract][Full Text] [Related]
52. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
[TBL] [Abstract][Full Text] [Related]
53. [Antibodies to glutamic acid decarboxylase in patients with Graves disease].
An Z; Zhao H; Li S; Zhao G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):98-9. PubMed ID: 15600194
[TBL] [Abstract][Full Text] [Related]
54. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.
Imagawa A; Hanafusa T; Miyagawa J; Matsuzawa Y
N Engl J Med; 2000 Feb; 342(5):301-7. PubMed ID: 10655528
[TBL] [Abstract][Full Text] [Related]
55. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
Schmidli RS; Colman PG; Harrison LC
J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
[TBL] [Abstract][Full Text] [Related]
56. Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain.
Mollo A; Hernandez M; Marsal JR; Esquerda A; Rius F; Blanco-Vaca F; Verdaguer J; Pozzilli P; de Leiva A; Mauricio D;
Diabetes Metab Res Rev; 2013 Sep; 29(6):446-51. PubMed ID: 23483713
[TBL] [Abstract][Full Text] [Related]
57. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
[TBL] [Abstract][Full Text] [Related]
58. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young.
Maltoni G; Zucchini S; Scipione M; Mantovani V; Salardi S; Cicognani A
Pediatr Diabetes; 2012 Mar; 13(2):208-12. PubMed ID: 21696527
[TBL] [Abstract][Full Text] [Related]
59. Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients.
Ng WY; Thai AC; Lui KF; Yeo PP; Cheah JS
Diabetes Res Clin Pract; 1999 Feb; 43(2):127-35. PubMed ID: 10221665
[TBL] [Abstract][Full Text] [Related]
60. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
